Hongting Lu

996 citations
39 papers · 752 indexed · h-index 14
Topics
Neuroblastoma Research and Treatments (15 papers)Cancer, Hypoxia, and Metabolism (7 papers)Cancer-related molecular mechanisms research (5 papers)
Partner nations
ChinaUnited StatesRussia

In The Last Decade

Hongting Lu

31 papers receiving 743 citations

Peers

Hongting Lu
Comparison fields: 5 of 81
  • Molecular Biology 390
  • Cancer Research 267
  • Immunology 226
  • Neurology 161
  • Oncology 151
Replace Long Hung with:
Long Hung United States
Amir Ben‐Shmuel Israel
María Pilar Armengol Spain
Biancamaria Ricci Italy
Martin Uhl Germany
Massimiliano Mazza Italy
Wenguang He China
Els Louagie Belgium
Zhongfang Zhao China
Hongting Lu relative to Long Hung United States Long Hung's profile →
Citations per field
00.5×1.5×1.9×
Long Hung · 1×
Citations per year

Countries citing papers authored by Hongting Lu

Since Specialization
Citations

This map shows the geographic impact of Hongting Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongting Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongting Lu more than expected).

Fields of papers citing papers by Hongting Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongting Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongting Lu. The network helps show where Hongting Lu may publish in the future.

Co-authorship network of co-authors of Hongting Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Hongting Lu. A scholar is included among the top collaborators of Hongting Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongting Lu. Hongting Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 4
4 0
5 0
6 4
7 0
8 4
9 2
10 4
11 46
12 38
13 81
14 1
15 0
16 8
17
Establishment of neuroblastoma (NB) cell line and induction of cell differentiation with all-trans retinoic acid
0
18 26
19 157
20 98

About Hongting Lu

Hongting Lu is a scholar working on Cancer Research, Neurology and Oncology, having authored 39 papers that have together received 752 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (15 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Cancer-related molecular mechanisms research (5 papers). The work is most often cited by research in Cancer Research (267 citations), Immunology (226 citations) and Neurology (161 citations). Hongting Lu has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Xiwei Hao, Richard M. Ransohoff, Jeremy M. Boss, Qian Dong, Lulu Han, Haihong Qin, Etty Benveniste, Philip H. Howe, Yi Han and Barbara A. Hocevar. Their work appears in journals such as The Journal of Experimental Medicine, The Journal of Immunology and Journal of Applied Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026